This company listing is no longer active
0GT7 Stock Overview
A biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
METabolic EXplorer S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.12 |
52 Week High | €0.98 |
52 Week Low | €0.12 |
Beta | 1.08 |
1 Month Change | 0% |
3 Month Change | 1.00% |
1 Year Change | -86.38% |
3 Year Change | -97.19% |
5 Year Change | -92.69% |
Change since IPO | -98.11% |
Recent News & Updates
Recent updates
Shareholder Returns
0GT7 | GB Chemicals | GB Market | |
---|---|---|---|
7D | 0% | -2.0% | 0.8% |
1Y | -86.4% | -22.9% | 4.4% |
Return vs Industry: 0GT7 underperformed the UK Chemicals industry which returned -33.1% over the past year.
Return vs Market: 0GT7 underperformed the UK Market which returned 6.4% over the past year.
Price Volatility
0GT7 volatility | |
---|---|
0GT7 Average Weekly Movement | n/a |
Chemicals Industry Average Movement | 5.9% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 10.6% |
10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: 0GT7's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 0GT7's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 450 | Benjamin Gonzalez | www.metabolic-explorer.com |
METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials.
METabolic EXplorer S.A. Fundamentals Summary
0GT7 fundamental statistics | |
---|---|
Market cap | €6.16m |
Earnings (TTM) | -€49.34m |
Revenue (TTM) | €168.17m |
0.0x
P/S Ratio-0.1x
P/E RatioIs 0GT7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0GT7 income statement (TTM) | |
---|---|
Revenue | €168.17m |
Cost of Revenue | €174.73m |
Gross Profit | -€6.56m |
Other Expenses | €42.78m |
Earnings | -€49.34m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.97 |
Gross Margin | -3.90% |
Net Profit Margin | -29.34% |
Debt/Equity Ratio | 122.3% |
How did 0GT7 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/08/03 00:59 |
End of Day Share Price | 2024/05/06 00:00 |
Earnings | 2023/06/30 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
METabolic EXplorer S.A. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Charles-Louis Planade | Arkeon Finance |
Arsene Guekam | CIC Market Solutions (ESN) |
Charles Bordes | Kepler Cheuvreux |